These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9045906)

  • 1. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes.
    Fiorillo MT; Meadows L; D'Amato M; Shabanowitz J; Hunt DF; Appella E; Sorrentino R
    Eur J Immunol; 1997 Feb; 27(2):368-73. PubMed ID: 9045906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subtypes of the HLA-B27 molecule and association with spondylarthropathies].
    Toubert A; Tieng V; Boisgérault F; Dulphy N; Tamouza R; Charron D
    Ann Med Interne (Paris); 1998 Apr; 149(3):145-8. PubMed ID: 11490536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated with ankylosing spondylitis.
    García F; Marina A; López de Castro JA
    Tissue Antigens; 1997 Mar; 49(3 Pt 1):215-21. PubMed ID: 9098927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1).
    García-Medel N; Sanz-Bravo A; Alvarez-Navarro C; Gómez-Molina P; Barnea E; Marcilla M; Admon A; de Castro JA
    Mol Cell Proteomics; 2014 Dec; 13(12):3367-80. PubMed ID: 25187574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of structural and thermodynamic studies of HLA-B27 subtypes exhibiting differential association with ankylosing spondylitis.
    Ziegler A; Loll B; Misselwitz R; Uchanska-Ziegler B
    Adv Exp Med Biol; 2009; 649():177-95. PubMed ID: 19731629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B.
    Rojo S; García F; Villadangos JA; López de Castro JA
    J Exp Med; 1993 Mar; 177(3):613-20. PubMed ID: 8436905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis.
    D'Amato M; Fiorillo MT; Carcassi C; Mathieu A; Zuccarelli A; Bitti PP; Tosi R; Sorrentino R
    Eur J Immunol; 1995 Nov; 25(11):3199-201. PubMed ID: 7489765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two HLA-B14 subtypes (B*1402 and B*1403) differentially associated with ankylosing spondylitis differ substantially in peptide specificity but have limited peptide and T-cell epitope sharing with HLA-B27.
    Merino E; Montserrat V; Paradela A; López de Castro JA
    J Biol Chem; 2005 Oct; 280(43):35868-80. PubMed ID: 16115862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in peptide-binding specificity of two ankylosing spondylitis-associated HLA-B27 subtypes.
    Fruci D; Butler RH; Greco G; Rovero P; Pazmany L; Vigneti E; Tosi R; Tanigaki N
    Immunogenetics; 1995; 42(2):123-8. PubMed ID: 7607703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HLA-B27 molecular subtypes and spondylarthropathies].
    Tieng V; Charron D; Toubert A
    Pathol Biol (Paris); 1998 Dec; 46(10):737-40. PubMed ID: 9922989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
    García-Peydró M; Martí M; López de Castro JA
    J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of the susceptibility difference between HLA-B*27:02/04/05 and HLA-B*27:06/09 to ankylosing spondylitis: substitution analysis, MD simulation, QSAR modelling, and in vitro assay.
    Cheng X; Mei Y; Ji X; Xue Q; Chen D
    SAR QSAR Environ Res; 2016 May; 27(5):409-25. PubMed ID: 27228481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The naturally occurring polymorphism Asp116-->His116, differentiating the ankylosing spondylitis-associated HLA-B*2705 from the non-associated HLA-B*2709 subtype, influences peptide-specific CD8 T cell recognition.
    Fiorillo MT; Greco G; Maragno M; Potolicchio I; Monizio A; Dupuis ML; Sorrentino R
    Eur J Immunol; 1998 Aug; 28(8):2508-16. PubMed ID: 9710228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability.
    Ramos M; Paradela A; Vazquez M; Marina A; Vazquez J; Lopez de Castro JA
    J Biol Chem; 2002 Aug; 277(32):28749-56. PubMed ID: 12042320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell responses against viral and self-epitopes and HLA-B27 subtypes differentially associated with ankylosing spondylitis.
    Fiorillo MT; Sorrentino R
    Adv Exp Med Biol; 2009; 649():255-62. PubMed ID: 19731635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Natural HLA-B*27:05 Ligandome by Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 2 (ERAP2).
    Lorente E; Fontela MG; Barnea E; Martín-Galiano AJ; Mir C; Galocha B; Admon A; Lauzurica P; López D
    Mol Cell Proteomics; 2020 Jun; 19(6):994-1004. PubMed ID: 32265295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.
    Seregin SS; Rastall DP; Evnouchidou I; Aylsworth CF; Quiroga D; Kamal RP; Godbehere-Roosa S; Blum CF; York IA; Stratikos E; Amalfitano A
    Autoimmunity; 2013 Dec; 46(8):497-508. PubMed ID: 24028501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism.
    Galocha B; Lamas JR; Villadangos JA; Albar JP; López de Castro JA
    Tissue Antigens; 1996 Nov; 48(5):509-18. PubMed ID: 8988533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis.
    Lamas JR; Paradela A; Roncal F; López de Castro JA
    Arthritis Rheum; 1999 Sep; 42(9):1975-85. PubMed ID: 10513815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel HLA-B27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20 S proteasome.
    Alvarez I; Sesma L; Marcilla M; Ramos M; Marti M; Camafeita E; de Castro JA
    J Biol Chem; 2001 Aug; 276(35):32729-37. PubMed ID: 11435436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.